Three selected hybridoma clones to convert stable cMAbs against BP and BM.

aThese 3 hybridoma clones were selected by their binding specificities, antigen reactivities to their bacterial cell components, and in vitro/vivo neutralizing activities against B. pseudomallei (BP) 8324 and/or B. mallei (BM) ATCC 23344. BT: B. thailandensis.bEach chimeric chain was assembled by the overlapping PCR. mVH: mouse variable heavy chain; HcG1: human constant gamma 1; mVL: mouse variable light chain; HcK: human constant kappa chain.